Determinants and measures of quality in oral anticoagulation therapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Hematology
Link
http://link.springer.com/content/pdf/10.1007/s11239-007-0106-9.pdf
Reference23 articles.
1. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E (2004) The pharmacology and management of the vitamin K antagonists: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126(3 Suppl):204S–233S
2. Ansell JE, Hughes R (1996) Evolving models of warfarin management: anticoagulation clinics, patient self-monitoring, and patient self-management. Am Heart J 132(5):1095–1100
3. Ansell JE, Buttaro ML, Thomas OV, Knowlton CH (1997) Consensus guidelines for coordinated outpatient oral anticoagulation therapy management. Anticoagulation guidelines task force. Ann Pharmacother 31(5):604–615
4. Schmitt L, Speckman J, Ansell J (2003) Quality assessment of anticoagulation dose management: comparative evaluation of measures of time-in-therapeutic range. J Thromb Thrombolysis 15(3):213–216
5. Loeliger EA (1985) Laboratory control, optimal therapeutic ranges, therapeutic quality control in oral anticoagulation. Acta Haematol 74(3):125–131
Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anticoagulation control among patients on vitamin K antagonists in nine countries in Sub-Saharan Africa;Journal of Thrombosis and Thrombolysis;2024-03-13
2. Enhancing postoperative anticoagulation therapy with remote patient monitoring: A pilot crossover trial study to evaluate portable coagulometers and chatbots in cardiac surgery follow-up;DIGITAL HEALTH;2024-01
3. Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis;Stroke;2023-11
4. Utility of a pharmacist-managed Anticoagulation Program in patients with congenital heart disease;Cardiology in the Young;2023-09-08
5. Decentralization and Virtualization of INR-based Anticoagulation Control During the COVID-19 Pandemic;Cardiovascular & Hematological Disorders-Drug Targets;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3